J Biol Chem, Vol. 275, Issue 3, 1731-1738, January 21, 2000
Ordered and Cooperative Binding of Opposing Globular Domains
of Calmodulin to the Plasma Membrane Ca-ATPase*
Hongye
Sun and
Thomas C.
Squier
From the Biochemistry and Biophysics Section, Department of
Molecular Biosciences, University of Kansas,
Lawrence, Kansas 66045-2106
 |
ABSTRACT |
We have investigated the mechanisms of activation
of the plasma membrane (PM) Ca-ATPase by calmodulin (CaM), which result in enhanced calcium transport rates and the maintenance of low intracellular calcium levels. We have isolated the amino- or
carboxyl-terminal domains of CaM (i.e. CaMN or CaMC),
permitting an identification of their relative specificity for binding
to sites on either the PM Ca-ATPase or a peptide (C28W) corresponding
to the CaM-binding sequence. We find that either CaMN or CaMC alone is
capable of productive interactions with the PM Ca-ATPase that induces
enzyme activation. There are, however, large differences in the
affinity and specificity of binding between CaMN and CaMC and either
C28W or the PM Ca-ATPase. The initial binding interaction between CaMC and the PM Ca-ATPase is highly specific, having approximately 10,000-fold greater affinity in comparison with CaMN. However, following the initial association of either CaMC or CaMN, there is a
300-fold enhancement in the affinity of CaMN for the secondary binding
site. Thus, while CaMC binds with a high affinity to the two
CaM-binding sites within the PM Ca-ATPase in a sequential manner, CaMN
binds cooperatively with a lower affinity to both binding sites. These
large differences in the binding affinities and specificities of the
amino- and carboxyl-terminal domains ensure that CaM binding to the PM
Ca-ATPase normally involves the formation of a specific complex in
which the initial high affinity association of the carboxyl-terminal
domain promotes the association of the amino-terminal domain necessary
for enzyme activation.
 |
INTRODUCTION |
A range of diverse metabolic activities involved in intracellular
signaling is mediated by calmodulin
(CaM),1 which functions as
the major calcium sensor in all eukaryotes. CaM binding to a range of
different target enzymes, including the plasma membrane (PM) Ca-ATPase,
has been suggested to result in an increase in enzymatic function as a
result of decreased contact interactions between the autoinhibitory
domain and catalytic domain elements that result in enhanced rates of
substrate binding or utilization (1). CaM binding involves two globular
domains, which are connected by an exposed
-helical element often
referred to as the central helix (2, 3). Upon calcium binding, the reorientation of
-helices function to expose hydrophobic binding sites within each domain element in CaM that are surrounded by charged
amino acids that lead to complex formation and activation of numerous
target proteins with little sequence homology (4-6). Backbone folds of
the amino- and carboxyl-terminal domains in CaM are structurally
similar, and in many instances either domain has been shown to
partially activate a range of different target proteins to varying
extents (7-9). However, despite the structural homology of the
individual CaM binding domains, target protein activation appears to
normally involve the specific association of the individual domain
elements with specific sequences within the CaM-binding sequence of
individual target proteins (7, 9-15). In the case of the PM Ca-ATPase,
the carboxyl-terminal domain of CaM has been suggested to be essential
for enzyme activation, whereas its amino-terminal domain has been
suggested to lack the ability to activate the PM Ca-ATPase without
prior association of the carboxyl-terminal domain (16, 17). Thus,
differences in the interactions between the amino- and
carboxyl-terminal domains of CaM and their corresponding binding sites
within target proteins have been suggested to play essential roles in
target protein activation. In this respect, previous measurements have
demonstrated that the binding preferences of individual CaM-binding
domains for sites within the CaM-binding sequence of skeletal myosin
light chain kinase are relatively small (i.e. less than 1 kcal/mol), suggesting the possibility of multiple conformations of
bound CaM that could function to regulate the extent of target protein activation observed in the presence of saturating CaM concentrations (9, 15). These observations suggest that differences in the maximal
extent of enzyme activation for the PM Ca-ATPase and other target
proteins observed in the presence of saturating CaM concentrations following a range of different post-translational modifications (e.g. phosphorylation or methionine oxidation),
site-directed deletions, and substitutions of specific amino acids may
all involve alterations in the binding mechanism between the opposing
globular domains in CaM and target proteins (7, 18-28). It is
therefore of interest to identify the binding mechanisms of CaM that
normally lead to enzymatic activation of the PM Ca-ATPase. To
accomplish this, we have cloned and expressed the amino-terminal domain
of CaM and isolated the carboxyl-terminal domain following trypsin digestion and HPLC purification, permitting us to determine the binding
specificities of the individual domains of CaM for the CaM-binding
sites within the PM Ca-ATPase and the abilities of the individual CaM
domains to induce enzyme activation. These measurements take advantage
of the fact that the binding affinity and conformation of CaM bound to
either a peptide corresponding to the CaM-binding sequence of the PM
Ca-ATPase (i.e. C28W) or to the entire PM Ca-ATPase are
virtually identical (13, 18, 29). We find that while occupancy of the
two binding sites on the PM Ca-ATPase with either CaM domain results in
complete enzyme activation, there are large differences in the
affinities and specificities of the carboxyl- and amino-terminal
domains for the sites within the CaM-binding sequence of the PM
Ca-ATPase. Thus, while the carboxyl-terminal domain binds sequentially
and independently to the two binding sites, the amino-terminal domain binds in a cooperative manner to both sites. The substantially higher
affinity of the carboxyl-terminal domain relative to the amino-terminal
domain suggests that activation of the PM Ca-ATPase normally involves
the initial association between the carboxyl-terminal domain of CaM to
a single site within the CaM-binding sequence of the PM Ca-ATPase,
followed by subsequent association with the amino-terminal domain.
 |
EXPERIMENTAL PROCEDURES |
Materials--
Trypsin and soybean trypsin inhibitor (STI) were
from Worthington. All other chemicals were obtained from Sigma and were
of the purest grade commercially available. The peptide C28W,
corresponding to the CaM-binding sequence of the PM Ca-ATPase
(LRRGQILWFRGLNRIQTQIRVVNAFRSS), was synthesized and purified by Quality
Control Co. (Hopkinton, MA). The entire vertebrate CaM or a CaM
fragment (CaMN) corresponding to first 77 amino acids in CaM was
overexpressed in Escherichia coli JM109 (DE3) cells and
purified using phenyl-Sepharose CL-4B (Amersham Pharmacia Biotech)
chromatography. A fragment corresponding to amino acids 78-148 (CaMC)
was obtained following trypsin digestion of CaM. In all cases, CaM or
its individual domain elements were purified using weak anion exchange
HPLC as described previously (30). Erythrocyte ghost membranes
containing the PM Ca-ATPase were purified as described
previously (21, 31).
Enzymatic Assays--
The CaM-dependent ATPase
activity associated with the PM Ca-ATPase was determined by measuring
phosphate release, essentially as described previously (21, 32). The
ghost membrane protein concentration was determined by the Biuret
method (33), using bovine serum albumin as the standard. CaM
concentration was determined using the Micro-BCA assay (Pierce), where
a stock solution of desalted CaM was used as a protein standard
(
277 = 3029 M-1
cm-1) (7). ATPase activity was measured at 37 °C in a
solution containing approximately 16 nM Ca-ATPase
(i.e. 0.4 mg ml
1 porcine erythrocyte ghost
membranes) in 100 mM HEPES (pH 7.5), 0.1 M KCl,
5 mM MgCl2, 0.1 mM EGTA, 0.44 mM CaCl2, 5 mM ATP, and 4 µM A23187. The free calcium concentration was calculated
to be 100 µM (34).
Purification of Amino- and Carboxyl-terminal Domains following
Proteolytic Cleavage of CaM--
Major tryptic fragments of CaM
corresponding to amino acids 1-75 (CaMN') and 78-148 (CaMC) were
purified using HPLC following proteolytic digestion, essentially as
described previously (7, 9). Briefly, 0.5 mg of CaM in 0.05 M NaCl, 40 mM NH4HCO3,
and 1 mM CaCl2 was incubated with 20 µg
ml
1 trypsin at 30 °C for 60 min. The reaction was
quenched by adding 100 µg mg
1 soybean trypsin
inhibitor, and the digest was directly loaded onto a J. T. Baker
(Phillipsburg, NJ) weak anion exchange HPLC column (WP PEI resin)
equilibrated with 25 mM Tris (pH 7.0) (buffer A) at room
temperature. The gradient was developed between buffer A and buffer B
(25 mM Tris (pH 7.0), 1 M
(NH4)2SO4). Buffer A was decreased
in 6 min from 99 to 88%, in 24 min from 88 to 56%, and in 2 min from
56 to 10%. The fractions of soybean trypsin inhibitor and trypsin were
identified by loading authentic standards separately injected onto the
column. Other fractions were collected and dialyzed exhaustively
against 10 mM NH4HCO3, lyophilized, and identified using electrospray ionization mass spectrometry essentially as described previously (35). Final protein concentrations were determined using published extinction coefficients, where
277(CaM) = 3029 M-1
cm-1,
259(CaMN) = 1680 M-1 cm-1, and
276(CaMC) = 3400 M-1
cm-1 (7).
Fluorescence Spectroscopy Measurements--
Steady-state
fluorescence spectra of 3 µM C28W in the presence of
variable CaM concentrations in 0.1 M HEPES (pH 7.5), 0.1 M KCl, and 0.5 mM CaCl2 (buffer C)
were measured using a Fluoro Max-2 spectrofluorometer (Jobin Yvon Spex;
Edison, NJ) equipped with a xenon lamp. Excitation was at 297 nm using
5-nm slit widths. When appropriate, fluorescence intensity changes
associated with CaM binding were detected at 370 nm subsequent to a
KV-320 long pass filter. Changes in the solvent accessibility of
Trp8 in C28W were assessed through collisional quenching,
where variable amounts of acrylamide (8 M stock) were added
in microliter increments to 3 µM C28W in the presence of
variable concentrations of CaM, CaMN, or CaMC in buffer C
(Vt = 2 ml).
Determination of Free CaM Concentrations and Binding Affinities
for the PM Ca-ATPase--
The concentration of CaM free in solution
was obtained from the following relationship,
|
(Eq. 1)
|
where Vmax is the maximal
calmodulin-dependent ATPase activity, V is
the observed ATPase activity at a defined concentration of
CaM, [CaM]free is the concentration of CaM free in
solution, [CaM]total is the total concentration of CaM
added to the solution, and [CaM]max is the total binding
capacity of the erythrocyte ghosts for CaM, which was estimated to
correspond to 40 pmol of CaM bound per mg of porcine erythrocyte ghost
(21).
The CaM-dependent activation of the PM Ca-ATPase by CaM
assumes an ordered binding mechanism of CaM with the CaM-binding sites (A-B) of the Ca-ATPase (see Scheme I) and
is described by the equation,
|
(Eq. 2)
|
where
|
(Eq. 3)
|
Span is the maximal CaM-dependent enzymatic activity
in the presence of saturating CaM, minimum represents the
CaM-independent enzymatic activity, and Y represents the PM
Ca-ATPase activity resulting from the association of both CaM domains
with the Ca-ATPase. [CaM]free is the concentration of CaM
not bound to the PM Ca-ATPase. [PMCA]total and
[PMCA]free, respectively, represent the total concentrations of the Ca-ATPase and the concentration of the Ca-ATPase with no CaM bound. K1 corresponds to the
equilibrium binding constant k1 of the
carboxyl-terminal domain of CaM to the Ca-ATPase, and K2 represents the product of the association
constants of both domains (i.e.
k12 × k3b),
where k3b is the apparent association constant
for the amino-terminal domain of CaM with the Ca-ATPase. An estimate of the actual association constant (k3) for the
amino-terminal domain can be obtained by taking into account the
effective concentration of the amino-terminal domain around the binding
site following association of the carboxyl-terminal domain, which
equals the following.
|
(Eq. 4)
|
The bulk concentration (b) of the amino-terminal
domain is assumed to correspond to 1/k1
(i.e. 10 nM). The concentration of the
amino-terminal domain (c) is approximately 1.4 mM and is calculated as follows.
|
(Eq. 5)
|
Na is Avogadro's number, and V is
the volume available to the amino-terminal domain, where the radius
corresponds to the overall length of CaM (approximately 100 Å after
association with the carboxyl-terminal domain) (36).
The activation of the PM Ca-ATPase by CaMC can be described by the
following equation.
|
(Eq. 6)
|
In this case, KU and KV,
respectively, correspond to k1 and
k1 × k2 in Scheme I and
represent the intrinsic equilibrium constants associated with ligand
binding to the two classes of CaM binding sites. If one assumes that
k1
k2, then site A
is essentially completely filled prior to the titration of site B (see
Scheme I), which is associated with the activation of the Ca-ATPase.
Under these latter conditions, the binding affinity of site B can be
described by the simple binding equation,
|
(Eq. 7)
|
The activation of the PM Ca-ATPase by CaMN can be described by
the following equation derived from Scheme
II.
|
(Eq. 8)
|
In this case, KP corresponds to
k1 + k2, and
KQ corresponds to k1 × k3 or k2 × k4 as defined in Scheme II. Likewise, activation
of the PMCa-ATPase by an equimolar mixture of CaMN and CaMC can be
described by the equation,
|
(Eq. 9)
|
where KA equals k1,
KB equals k1 × k2, and KC equals
k1 × k3.
[CaMN]free and [CaMC]free are the unbound
concentration of the N-terminal and C-terminal domains of CaM,
respectively.
 |
RESULTS |
Purification of CaM Fragments--
CaM contains two binding sites
that associate with target proteins located in the amino- and
carboxyl-terminal domain (1, 6), respectively. Following mild trypsin
digestion, it is possible to isolate an amino-terminal fragment
containing amino acids Ala1-Lys75 (CaMN') and
Asp78 -Lys148 (CaMC) using weak anion exchange
HPLC. The identity of these fragments was determined using electrospray
ionization mass spectrometry; the observed average molecular masses of
CaMN' and CaMC are 8316 ± 1 and 8147 ± 1 Da, respectively,
in close agreement with expected monoisotopic molecular masses of
8316.2 and 8147.8 Da for these CaM fragments. These results suggest
that previous measurements in which the amino-terminal domain of CaM
was reported to be unable to activate the PM Ca-ATPase probably
involved CaMN' (16). However, in case Met76 and
Lys77 located in the linker region between the amino- and
carboxyl-terminal domains might play a role in facilitating target
protein binding, we have cloned and expressed the amino-terminal domain
of CaM containing amino acids Ala1-Lys77
(CaMN) in E. coli. CaMN was purified using a
phenyl-Sepharose hydrophobic column essentially as described for intact
CaM (30), and was subsequently purified using weak anion exchange HPLC. Using electrospray ionization mass spectrometry, we found that CaMN has
an observed average molecular mass of 8576 ± 1 Da, in close
agreement with the expected average molecular mass of 8575.6 Da.
CaM-dependent Activation of the PM Ca-ATPase--
CaM
activates the PM Ca-ATPase; the amount of CaM necessary for
half-maximal activation is 3.9 ± 0.4 nM (Fig.
1). A similar level of enzymatic
activation of the PM Ca-ATPase is observed in the presence of
saturating concentrations of either CaMN or CaMC. Thus, in contrast to
previous reports where CaMN' was found to lack the ability to activate
the Ca-ATPase (16), we found that the inclusion of two additional amino
acids in CaMN provided an amino-terminal domain fully capable of
activation of the PM Ca-ATPase. However, the apparent affinities of
these isolated domains are dramatically lower; half-maximal activation
occurs at 6 ± 1 µM CaMN and 1.7 ± 0.2 µM CaMC (Table I). The
1500- and 400-fold higher concentrations, respectively, of CaMN or CaMC necessary for enzyme activation indicate that (i) individual CaM binding domains are not equivalent and may preferentially interact with
one of the two binding sites on the CaM-binding sequence and (ii) that
the central helix, which functions to join the individual domains of
CaM, facilitates specific association of individual domains with their
target sites on the Ca-ATPase. The role of the central helix and
possible differences in the binding specificity of individual CaM
domains was further assessed by adding an equimolar mixture of CaMN and
CaMC, which results in activation of the PM Ca-ATPase, with a
half-maximal activation of enzymatic activity occurring with a
concentration of both fragments of 0.35 ± 0.02 µM
(Fig. 1). The requirement of 100-fold higher concentrations of CaMN and
CaMC for enzyme activation relative to that required for intact CaM
indicates that the central helix facilitates binding and enzyme
activation, in agreement with previous observations (37-39). The
approximately 4-fold lower concentration of CaMC necessary for
half-maximal activation using a combination of CaMC and CaMN relative
to that observed using CaMC alone is consistent with previous
suggestions that the carboxyl- and amino-terminal domains of CaM may
have different specificities for the two CaM-binding sites within the
CaM-binding sequence of the PM Ca-ATPase (13). To further understand
possible differences in the individual domains of CaM in the activation
mechanism of the Ca-ATPase, additional measurements of possible
differences in binding specificity are necessary.

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 1.
Activation of the PM Ca-ATPase by native CaM
and individual domain elements. Activation of the PM Ca-ATPase in
porcine erythrocyte ghosts was measured as a function of CaMX,
corresponding to native CaM ( ), the amino-terminal domain, CaMN
( ), the carboxyl-terminal domain, CaMC ( ), and an equimolar
concentration of CaMN and CaMC ( ). Lines represent least
squares fits to the data, as described under "Results." PM
Ca-ATPase activity was measured at 37 °C; maximal enzymatic activity
was approximately 7.2 µmol mg 1 h 1.
|
|
View this table:
[in this window]
[in a new window]
|
Table I
Equilibrium binding affinities between CaM domains and the plasma
membrane Ca-ATPase
Equilibrium association constants were derived from macroscopic
equilibrium constants obtained from fitting data in Fig. 1 to Equation 2 (CaM), Equation 8 (CaMN), Equation 6 (CaMC), and Equation 9
(CaMN + CaMC), where relationships between derived binding
constants and the mechanisms of CaM association are illustrated in
Schemes I and II. Values in parentheses represent the S.D. of the
measurement.
|
|
Binding Specificity of Individual Domains to the Plasma Membrane
Ca-ATPase--
CaM has previously been shown to bind with the same
conformation and a comparable affinity to either the PM Ca-ATPase in
erythrocyte ghosts or the peptide C28W, corresponding to the
CaM-binding sequence of the PM-Ca-ATPase (13, 18, 29, 40). To monitor
CaM association with C28W, we have measured the fluorescence emission
of Trp8 in C28W, which undergoes an 8-nm spectral blue
shift upon CaM association (Fig. 2). A
similar blue shift in the emission maximum of Trp8 in C28W
occurs upon association of individual CaM domains with C28W, suggesting
similar environments around Trp8 in all cases. Thus,
binding interactions between either CaMN or CaMC and C28W are similar
to that observed using intact CaM, suggesting that both CaM domains can
bind to the two sites on C28W. There are small differences in the
fluorescence intensity of Trp8 in C28W bound to CaM in
comparison with CaMN or CaMC. In comparison with intact CaM, binding of
the carboxyl- and amino-terminal domains to C28W, respectively, results
in an 8% decrease and a 18% increase in the quantum yield to
Trp8 in C28W (Fig. 2).

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 2.
Fluorescence emission spectra of
Trp8 in C28W. Spectra were obtained for 3 µM C28W, corresponding to the CaM-binding sequence of the
PM Ca-ATPase, in buffer C before (thick solid line;
F353 = 1.00) and after association of 3 µM CaM (dotted line;
F345 = 1.02), 6 µM CaMN
(dashed line; F346 = 1.18), or 6 µM CaMC (thin solid line;
F345 = 0.92). Excitation was 297 nm.
|
|
Upon titration of C28W with CaM, there is a monophasic decrease in the
fluorescence signal, resulting in a 32% reduction in fluorescence
intensity at an equimolar ratio of CaM relative to C28W (Fig.
3). These results are consistent with the
specific association between CaM and binding sites on C28W. In
contrast, upon the addition of either CaMN or CaMC there is a biphasic
change in fluorescence intensity, suggesting a differential occupancy of the two binding sites on C28W by these CaM fragments. Thus, titration with CaMN results in an initial increase in the fluorescence intensity followed by a progressive decline in fluorescence intensity, while titration with CaMC results in an initial decrease in
fluorescence intensity followed by a progressive increase in
fluorescence intensity. These results indicate that there are
substantial differences in the binding specificities of individual CaM
binding domains with respect to the two binding sites within the
CaM-binding sequence of C28W.

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 3.
Binding specificity of individual CaM domains
for C28W. Fluorescence emission intensity was monitored for
Trp8 in C28W (3 µM) as a function of the
molar ratio of CaM ( ), CaMN ( ), and CaMC ( ). Using either
Scheme I or Scheme II, the lines represent best fits to the
data for CaM (solid line), CaMN
(dotted line), and CaMC (dashed
line). Binding constants of individual domains were assumed
to be identical to those determined for the PM Ca-ATPase in Table I,
except for k1(CaMN), which was 4 × 104 M 1. Experimental conditions
are as indicted in the legend to Fig. 2. Excitation was at 297 nm, and
fluorescence emission was detected subsequent to a Schott KV-370 long
pass filter.
|
|
A more quantitative determination of possible differences in the
binding specificities of individual domain elements for the two binding
sites on C28W involved measurements of the solvent accessibility of
Trp8 at varying stoichiometries of either the amino- or
carboxyl-terminal domain of CaM. The fluorescence intensity of
Trp8 is very sensitive to the presence of the collisional
quencher acrylamide in the absence of CaM (Fig.
4), indicating a large degree of solvent
exposure. CaM binding results in a large decrease in the solvent
accessibility of Trp8, consistent with the suggested
important role of this aromatic residue in defining the productive
interaction between hydrophobic sites within CaM and the CaM-binding
sequence of a large number of target proteins, including the PM
Ca-ATPase (1). A similar reduction in the solvent accessibility of
Trp8 is observed upon the addition of 1 mol of CaMC/mol of
C28W. The addition of increasing amounts of CaMC has little effect on
the solvent accessibility of Trp8 in C28W, indicating that
CaMC preferentially binds to site A (see Scheme I) in the vicinity of
Trp8 near the amino terminus of the CaM-binding sequence.
In contrast, the addition of an equimolar concentration of CaMN to C28W
results in an intermediate solvent accessibility between that of C28W alone and the complex between CaMC and C28W (Fig. 4B). The
solvent accessibility is further reduced upon the addition of
increasing amounts of CaMN. The addition of 2 mol of CaMN/mol of C28W
results in a solvent accessibility comparable with that observed when 1 mol of CaMC/mol of C28W is added. Thus, association of the
carboxyl-domain of CaM with C28W is sequential, with initial high
affinity binding occurring at site A in the vicinity of
Trp8 followed by the association of CaMC with site B (see
Scheme I). In contrast, CaMN binds to both binding sites on C28W upon
the addition of an equimolar concentration of CaMN to C28W, suggesting that CaMN binds to sites A and B with a similar affinity
(i.e. k1 and
k2 have comparable affinities in Scheme II).
Alternatively, binding of CaMN to a primary binding site may induce
structural changes within C28W that result in an enhanced affinity
between CaMN and the secondary binding site as a result of cooperative structural changes involving the binding sites within C28W, as previously suggested for other target enzymes (9, 15). From these
results, we can conclude that CaMC specifically binds to site A before
it binds to site B, while CaMN binds to both sites on the enzyme with a
similar affinity; there are interactions between sites A and B as
indicated by the biphasic fluorescence response (Fig. 3). These
conclusions justify the models described under "Experimental
Procedures" for fitting the enzymatic activation of the PM Ca-ATPase
by CaM, CaMN, or CaMC.

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 4.
Solvent accessibility of Trp8 in
C28W. Collisional quenching efficiencies were determined for 3 µM C28W alone ( ) and following the addition of 3 µM CaM ( ), 3 µM CaMN ( ), 6 µM CaMN ( ), 3 µM CaMC ( ), and 6 µM CaMC ( ). Inset, alterations in the
Stern-Volmer collisional quenching efficiency
(KSV) relative to the C28W alone
(KSV(C28W)) as a function of the molar
stoichiometry of CaMN ( ) or CaMC ( ). Experimental conditions are
as indicted in the legend to Fig. 2, where ex = 297 nm
and em = 352 nm.
|
|
Calculation of Binding Affinities between CaM and the PM
Ca-ATPase--
The CaM-dependent activation of the PM
Ca-ATPase by CaM, CaMN, or CaMC was used to estimate the binding
affinities between individual domains of CaM and the CaM-binding
sequence of PM Ca-ATPase. This analysis takes into account that CaM
contains two binding domains and that both domains must associate with
binding sites within the CaM-binding sequence of the PM Ca-ATPase to
induce enzyme activation, in analogy to other CaM-dependent
enzymes (9, 15). Initial binding between CaM and target proteins,
including the PM Ca-ATPase, has been suggested to involve the high
affinity association of the carboxyl-terminal domain of CaM (Refs. 1 and 16; see above), and that association of the amino-terminal domain
is aided by the reduced volume available for its diffusion due to the
association of the carboxyl-terminal domain of CaM to the PM Ca-ATPase
(9, 37, 38). Therefore, we have fit the CaM-dependent
activation of the PM Ca-ATPase to Equation 2, which assumes an ordered
binding mechanism of CaM with the Ca-ATPase (see Scheme I). A least
squares fit to the data for PM Ca-ATPase activation by intact CaM in
Fig. 1 indicates that k1 = 1.0 ± 0.1 × 108 M
1 and
k3b = 5 ± 4 × 109
M
1. Following correction for the large
increase in the effective concentration of the amino-terminal domain
following binding of the carboxyl-terminal domain (see Equation 4), one
can estimate that the equilibrium binding constant for the
amino-terminal domain for site B within the CaM-binding sequence of the
PM Ca-ATPase is approximately 1 × 105
M
1 (Table I), in agreement with previous
determinations of the affinity of the amino-terminal domain of CaM to
phosphodiesterase, myosin light chain kinase, and nitric-oxide synthase
(7-9, 15).
In the case of a homogeneous population of a single domain of CaM
(i.e. CaMN or CaMC), the activation of the PM Ca-ATPase (Y) requires that the individual domains of CaM associate
with both binding sites within the CaM-binding sequence of the PM
Ca-ATPase. This is equivalent to a single ligand binding to multiple
sites on an enzyme, where occupancy of both sites is necessary for
activation, and can be described using Equation 6 for the activation of
the PM Ca-ATPase by CaMC. Fitting the data in Fig. 1 for CaMC, we are
unable to obtain an accurate estimate of k1.
However, if one assumes that k1 equals 1.0 ×108 M
1 as determined for intact
CaM (see above), then a least squares fit to the data indicates that
k2 equals 0.7 ± 0.1 × 106 M
1 (Table I). Since
k1
k2, site A is
essentially completely filled prior to the titration of site B (see
Scheme I), which is associated with the activation of the Ca-ATPase.
Under these latter conditions, the binding affinity of site B can be
described by the simple binding equation (see Equation 7), which
adequately describes the data in Fig. 1. A least squares fit to the
data indicates that k2 equals 1.1 ± 0.1 × 106 M
1. The latter
estimate of the binding affinity is in close agreement to that obtained
using Equation 6 and is consistent with the CaMC concentration
necessary for half-maximal maximal activation (i.e. [CaMC]1/2 = 1.7 ± 0.2 µM).
The activation of the PM Ca-ATPase by CaMN requires that binding to
sites A and B on C28W in Scheme II be taken into account, since the
data in Fig. 1 cannot be fit to a simple model involving a homogeneous
population of binding sites as observed for CaMC (see above).
Therefore, we have fit the CaMN-dependent activation of the
PM Ca-ATPase using Equation 8. If one assumes that
k1 = k2 and
k3 = k4, then
k1 equals 1 ± 1 × 104
M
1, and k3 equals
3.2 ± 0.5 × 106 M
1
(Table I). These values indicate that occupancy of one binding site
with CaMN induces cooperative structural changes that enhance the
affinity of CaMN binding to the other site. Similar binding affinities
were obtained for CaMN binding to gizzard myosin light chain kinase
(9), suggesting that the low affinity and cooperative association of
the amino-terminal domain with some target enzymes may be a general
feature involving CaM binding that is fundamental to their activation mechanism.
Additional understanding of the binding mechanism of CaM to the PM
Ca-ATPase is possible from a consideration of the activation of the
Ca-ATPase by a mixture of CaM domains, which is simplified by the
substantially larger binding affinity and specificity of the
carboxyl-terminal domain of CaM for site A within the CaM-binding sequences of the Ca-ATPase relative to the amino-terminal domain (see
above). Therefore, upon titration of the PM Ca-ATPase with an equal
concentration of the amino- and carboxyl-terminal domains, the high
affinity association of the carboxyl-terminal domain ensures that
enzyme activation (Y) is the result of the association of
either the amino- or carboxyl-terminal domain with a single site
(i.e. site B in Scheme I) on the PM Ca-ATPase, which can be
described using Equation 9. Consistent with the binding affinity determined from a consideration of the CaMN-dependent
activation of the PM Ca-ATPase, a least squares fit to the data in Fig.
1 indicates that for a mixture of CaMN and CaMC that
k3 equals 2.7 ± 0.3 × 106 M
1, where
k1 and k2 are
independently determined from a consideration of the activation of the
PM Ca-ATPase by either CaM or CaMC, respectively. Thus, occupancy of
site A enhances that affinity of CaMN by approximately 300-fold,
consistent with earlier results obtained using gizzard myosin light
chain kinase (9). These results indicate that a cooperative binding
mechanism between the carboxyl- and amino-terminal domains of CaM
through structural changes involving the CaM-binding sequence is
important in facilitating CaM binding and that the central helix is not
necessary to promote cooperative binding and enzyme activation.
 |
DISCUSSION |
The isolated amino- and carboxyl-terminal domains of CaM
(i.e. CaMN and CaMC) are both able to fully activate the PM
Ca-ATPase (Fig. 1), indicating that these structurally homologous
domains are able to bind productively to either binding site within the CaM-binding sequence of the PM Ca-ATPase so as to induce the normal structural changes associated with enzyme activation. However, while
CaMC binds sequentially to the two sites within the CaM-binding sequence with high affinity, we find that CaMN binds with a lower affinity to both sites in a highly cooperative manner (Figs. 3 and 4;
Table I). These large differences with respect to the affinity and
binding specificity are the result of a 10,000-fold higher affinity for
the initial binding interaction between CaMC and the CaM-binding
sequence of the PM Ca-ATPase in comparison with that observed for CaMN,
which functions to ensure a unique orientation of the complex between
CaM and the CaM-binding sequence of the PM Ca-ATPase necessary for
productive binding and enzyme activation. The two binding sites within
the CaM-binding sequence of the PM Ca-ATPase are structurally coupled,
as indicated by the biphasic fluorescence changes and the cooperative
binding between CaMN domains that results in a 300-fold increase in the binding affinity for the secondary site as a result of the occupancy of
the primary binding site (Fig. 3; Table I). However, following the
initial association of either domain, the affinity of CaMC or CaMN for
the secondary site is very similar (Table I). These results suggest
that the molecular determinants that define binding to the secondary
site are relatively nonspecific and emphasize that the binding
specificity of the carboxyl-terminal domain defines the correct
orientation of the complex between CaM and the CaM-binding sequence of
the PM Ca-ATPase. Thus, the initial specific binding of CaMC to the
high affinity site promotes the cooperative binding of CaMN to the
secondary site necessary for rapid enzyme activation.
Role of Individual CaM Domains in Promoting Enzyme
Activation--
Previous measurements demonstrated that an
HPLC-purified carboxyl-terminal fragment following trypsin digestion
(CaMC) is able to fully activate the PM Ca-ATPase (16), in agreement
with the present results (see Fig. 1). In contrast, the isolated
amino-terminal fragment purified following trypsin digestion of CaM
(now known to correspond to CaMN') was unable to significantly activate
the PM Ca-ATPase or a range of other CaM-dependent enzymes
in the absence of CaMC (7, 9, 16), suggesting that there may be
distinct structural requirements associated with the recognition elements of each CaM domain and the corresponding binding sites on the
PM Ca-ATPase. In contrast, we have demonstrated using CaMC and CaMN
that either domain of CaM can fully activate the PM Ca-ATPase (Fig. 1).
Differences between our results and those previously reported may be
related to the additional two amino acids (i.e. Met76 and Lys77) found in CaMN relative to
CaMN'. Thus, the inability of CaMN' to activate the PM Ca-ATPase may be
the result of a requirement for specific binding interactions involving
Met76 or Lys77 either with the CaM-binding
sequence of the PM Ca-ATPase or other residues within the
amino-terminal domain of CaM that stabilizes the tertiary structure of
CaMN. However, irrespective of the physical reasons, these results
indicate that either domain of CaM is able to productively associate
with the CaM-binding sequence of the PM Ca-ATPase to promote enzyme
activation, and they emphasize the flexibility of the recognition
elements within individual CaM binding domains that promotes binding to
a range of different sequences. Thus, under equilibrium conditions, the
PM Ca-ATPase has minimal structural requirements for specific side
chain interactions involving either CaM domain to promote enzyme
activation of the PM Ca-ATPase, and CaM-dependent
activation appears to be simply a matter of occupying both binding
sites to promote enzyme activation on a time scale appropriate to
calcium signaling. However, because of the large differences in the
binding affinities of the amino- and carboxyl-terminal domains (Table
I), under normal physiological conditions CaM binds to the CaM-binding
sequence of the PM Ca-ATPase in a unique orientation, with the
carboxyl-terminal domain of CaM in association with the amino-terminal
portion of the CaM-binding peptide. The latter binding orientation is
in agreement with previous measurements obtained through a
consideration of intermolecular distances between CaM and C28W obtained
using fluorescence resonance energy transfer (13).
Proposed Binding Mechanism of CaM to the PM Ca-ATPase--
The
specific binding of CaM to the PM Ca-ATPase in a unique orientation is
the result of the 10,000-fold higher affinity of the carboxyl-terminal
domain for the primary binding site (i.e. site A in Scheme
I) relative to the amino-terminal domain. Following initial association
of the carboxyl-terminal domain with the CaM-binding site of the PM
Ca-ATPase, cooperative structural changes within the CaM-binding
sequence enhance the binding of the amino-terminal domain necessary for
enzyme activation. In addition, there is a 40,000-fold increase in the
effective concentration of the amino-terminal domain following the
binding of the carboxyl-terminal domain as a result of the structural
linkage between these domains through the central helix (see Equation 4). These results suggest that there is no need for a high intrinsic
affinity between the amino-terminal domain and the CaM-binding sequence
in order to quickly saturate the secondary binding site in the presence
of activating calcium. Similar cooperative binding interactions have
been observed between individual CaM domains and the CaM-binding
sequence in myosin light chain kinase (9), suggesting that enhanced
binding interactions involving a structural linkage between two binding
sites of the CaM-binding sequence may be a common feature for
CaM-dependent enzymes. Since the crystal structures of CaM
bound to the CaM-binding sequences of myosin light chain kinase or
multifunctional CaM-dependent kinase II indicate that the
CaM-binding sequences adopt a
-helical structure, the basis for
these cooperative interactions may involve secondary structural changes
within the CaM-binding sequence following association of the
carboxyl-terminal domain. It is interesting that the binding constant
of the amino-terminal domain in intact CaM is approximately 1 order of
magnitude weaker than that of CaMN (Table I), suggesting that stearic
constraints imposed by the central helix restrict the binding
interaction. However, from a practical point of view, the 40,000-fold
enhancement in the apparent binding affinity
(k3b) compensates for the small reduction in
k3 for the amino-terminal domain in intact CaM
relative to that of CaMN and is sufficient to ensure the saturation of
the secondary binding site by the amino-terminal domain under
conditions of activating calcium.
Possible Physiological Role for the Differential Binding of
Individual CaM Domains--
Large differences in the binding
affinities of the two domains in CaM have previously been suggested to
offer important advantages in terms of rapidly regulating enzyme
function (14, 36). It is therefore possible for the high affinity
carboxyl-terminal domain to preferentially bind to target enzymes at
low calcium concentrations so as to promote the rapid binding of the
amino-terminal domain necessary for enzyme activation following
transient increases in cytosolic calcium concentrations. In addition,
post-translational modifications that alter the apparent affinity of
the amino-terminal domain can differentially activate target protein
function by modifying the binding of the amino-terminal domain
necessary for enzyme activation (9, 14). Thus, enzymes such as neuronal nitric-oxide synthase have been suggested to bind CaM at low calcium concentrations through the modulation of the affinity of the amino terminus and the CaM-binding sequence (9). Likewise, the oxidative modification of methionines in CaM have been shown to preferentially decrease the binding affinity of the amino terminus of CaM to the
CaM-binding sequence of the PM Ca-ATPase and to decrease the maximal
activation in the presence of saturating CaM concentrations (21, 27,
35). It should be noted that a large difference in binding affinity is
required to permit the selective binding of the carboxyl-terminal
domain of CaM at low (i.e. resting) calcium levels, since
the presence of target peptides has previously been shown to result in
a 100-fold increase in the apparent calcium affinity of CaM (41).
Therefore, the approximately 100-fold difference in the affinities of
the carboxyl-terminal domain for site A and the amino-terminal domain
for site B following association of the carboxyl-terminal domain
suggest that at low calcium concentrations the carboxyl-terminal domain
(which has a 10-fold higher calcium affinity) (42) may preferentially
associate with the PM Ca-ATPase in an inactive conformation. Under
these conditions, the enhanced calcium affinity of the individual
domains of CaM in the presence of target peptides would not be enough
to promote binding of the amino-terminal domain. Small increases in
calcium concentrations would result in rapid binding of the
amino-terminal domain, which has the potential to ensure the rapid
activation of the PM Ca-ATPase necessary for rapid calcium
resequestration. Likewise, small decreases in the binding affinity as a
result of post-translational modifications would have the potential to
result in a reduction in the maximal levels of activation, consistent
with the observation that oxidized CaM functions as an antagonist with
respect to the activation of the PM Ca-ATPase by native (unoxidized)
CaM (21).
Conclusions and Future Directions--
We have demonstrated that
occupancy of the two binding sites within the CaM-binding sequence of
the PM Ca-ATPase with either domain of CaM is sufficient to fully
activate the PM Ca-ATPase, indicating that there are no specific
requirements involving side chain interactions between individual
CaM-binding domains and the PM Ca-ATPase necessary for enzyme
activation. However, under normal conditions, the carboxyl-terminal
domain specifically associates with a unique site near the amino
terminus of the CaM-binding sequence. Following association of the
carboxyl-terminal domain, cooperative structural changes between the
primary and secondary binding sites within the CaM-binding sequence and
the large increase in the effective concentration of the amino-terminal
domain function to enhance the binding of the amino-terminal domain
necessary for enzyme activation. Future studies need to correlate
structural changes within the CaM-binding sequence to occupancy of the
individual binding sites and investigate the influence of
post-translational modifications involving both CaM and the PM
Ca-ATPase on the binding affinities and cooperative interactions
between individual CaM domains and binding sites on the PM
Ca-ATPase.
 |
ACKNOWLEDGEMENTS |
We thank Diana J. Bigelow for insightful
discussions and Dan Yin and Robert F. Weaver for advice and technical assistance.
 |
FOOTNOTES |
*
This work was supported by National Institutes of Health
Grant AG 12993.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.: 785-864-4008;
Fax: 785-864-5321; E-mail: TSQUIER@UKANS.EDU.
 |
ABBREVIATIONS |
The abbreviations used are:
CaM, calmodulin;
CaMN, N-terminal domain of calmodulin containing amino acids 1-77;
CaMN', N-terminal domain of calmodulin containing amino acids 1-75;
CaMC, C-terminal domain of calmodulin containing amino acids 78-148;
PM, plasma membrane;
C28W, a peptide identical to the CaM-binding
sequence of the PM Ca-ATPase with the sequence
LRRGQILWFRGLNRIQTQIRVVNAFRSS;
HPLC, high performance liquid
chromatography.
 |
REFERENCES |
| 1.
|
Crivici, A.,
and Ikura, M.
(1995)
Annu. Rev. Biophys. Biomol. Struct.
24,
85-116[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Babu, Y. S.,
Bugg, C. E.,
and Cook, W. J.
(1988)
J. Mol. Biol.
204,
191-204[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Chattopadhyaya, R.,
Meador, W. E.,
Means, A. R.,
and Quiocho, F. A.
(1992)
J. Mol. Biol.
228,
1177-1192[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Kuboniwa, H.,
Tjandra, N.,
Grzesiek, S.,
Ren, H.,
Klee, C. B.,
and Bax, A.
(1995)
Nat. Struct. Biol.
2,
768-776[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Zhang, M.,
Tanaka, T.,
and Ikura, M.
(1995)
Nat. Struct. Biol.
2,
758-767[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Tjandra, N.,
Bax, A.,
Crivici, A.,
and Ikura, M.
(1999)
in
Calcium in Cellular Regulation
(Carafoli, E.
, and Klee, C., eds)
, pp. 152-170, Oxford University Press, Oxford
|
| 7.
|
Newton, D. L.,
Oldewurtel, M. D.,
Krinks, M. H.,
Shiloach, J.,
and Klee, C. B.
(1984)
J. Biol. Chem.
259,
4419-4426[Abstract/Free Full Text]
|
| 8.
|
Newton, D. L.,
Klee, C.,
Woodgett, J.,
and Cohen, P.
(1985)
Biochim. Biophys. Acta
845,
533-539[Medline]
[Order article via Infotrieve]
|
| 9.
|
Persechini, A.,
McMillan, K.,
and Leakey, P.
(1994)
J. Biol. Chem.
269,
16148-16154[Abstract/Free Full Text]
|
| 10.
|
Meador, W. E.,
Means, A. R.,
and Quiocho, F. A.
(1992)
Science
257,
1251-1254[Abstract/Free Full Text]
|
| 11.
|
Meador, W. E.,
Means, A. R.,
and Quiocho, F. A.
(1993)
Science
262,
1718-1721[Abstract/Free Full Text]
|
| 12.
|
Ikura, M.,
Clore, G. M.,
Gronenborn, A., M.,
Zhu, G.,
Klee, C. B.,
and Bax, A.
(1992)
Science
256,
632-638[Abstract/Free Full Text]
|
| 13.
|
Chapman, E. R.,
Alexander, K.,
Vorherr, T.,
Carafoli, E.,
and Storm, D. R.
(1992)
Biochemistry
31,
12819-12825[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Bayley, P. M.,
Findlay, W. A.,
and Martin, S. R.
(1996)
Protein Sci.
5,
1215-1228[Abstract]
|
| 15.
|
Barth, A.,
Martin, S. R.,
and Bayley, P. M.
(1998)
J. Biol. Chem.
273,
2174-2183[Abstract/Free Full Text]
|
| 16.
|
Guerini, D.,
Krebs, J.,
and Carafoli, E.
(1984)
J. Biol. Chem.
259,
15172-15177[Abstract/Free Full Text]
|
| 17.
|
Elshorst, B.,
Hennig, M.,
Försterling, H.,
Diener, A.,
Maurer, M.,
Schulte, P.,
Chwalbe, H.,
Friesinger, C.,
Krebs, J.,
Schmid, H.,
Vorherr, T.,
and Carafoli, E.
(1999)
Biochemistry
38,
12320-12332[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Vorherr, T.,
James, P.,
Krebs, J.,
Enyedi, A.,
McCormick, D. J.,
Penniston, J. T.,
and Carafoli, E.
(1990)
Biochemistry
29,
355-365[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Quadroni, M.,
L'Hostis, E. L.,
Corti, C.,
Myagkikh, I.,
Durussel, I.,
Cox, J.,
James, P.,
and Carafoli, E.
(1998)
Biochemistry
37,
6523-6532[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Zhang, M.,
Li, M.,
Wang, J. H.,
and Vogel, H. J.
(1994)
J. Biol. Chem.
269,
15546-15552[Abstract/Free Full Text]
|
| 21.
|
Yao, Y.,
Yin, D.,
Jas, G.,
Kuczera, K.,
Williams, T. D.,
Schöneich, C.,
and Squier, T. C.
(1996)
Biochemistry
35,
2767-2787[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Persechini, A.,
Gansz, K. J.,
and Paresi, R. J.
(1996)
J. Biol. Chem.
271,
19279-19282[Abstract/Free Full Text]
|
| 23.
|
Chin, D.,
and Means, A. R.
(1996)
J. Biol. Chem.
271,
30465-30471[Abstract/Free Full Text]
|
| 24.
|
Chin, D.,
Soan, D. J.,
Quiocho, F. A.,
and Means, A. R.
(1997)
J. Biol. Chem.
272,
5510-5513[Abstract/Free Full Text]
|
| 25.
|
Chin, D.,
Winkler, K. E.,
and Means, A. R.
(1997)
J. Biol. Chem.
272,
31235-31240[Abstract/Free Full Text]
|
| 26.
|
Edwards, R. A.,
Walsh, M. P.,
Sutherland, C.,
and Vogel, H. J.
(1998)
Biochem. J.
331,
149-152
|
| 27.
|
Gao, J.,
Yin, D.,
Yao, Y.,
Williams, T. D.,
and Squier, T. C.
(1998)
Biochemistry
37,
9536-9548[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Yuan, T.,
and Vogel, H. J.
(1999)
Protein Sci.
8,
113-121[Abstract]
|
| 29.
|
Yao, Y.,
Gao, J.,
and Squier, T. C.
(1996)
Biochemistry
35,
12015-12028[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Sun, H.,
Yin, D.,
and Squier, T. C.
(1999)
Biochemistry
38,
12266-12279[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Niggli, V.,
Penniston, J. T.,
and Carafoli, E.
(1979)
J. Biol. Chem.
254,
9955-9958[Abstract/Free Full Text]
|
| 32.
|
Lanzetta, P. A.,
Alverez, L. J.,
Reinsch, P. S.,
and Candia, O.
(1979)
Anal. Biochem.
100,
95-97[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Gornal, A.,
Bardawill, C.,
and David, M.
(1949)
J. Biol. Chem.
177,
751-766[Free Full Text]
|
| 34.
|
Fabiato, A.
(1988)
Methods Enzymol.
157,
378-417[Medline]
[Order article via Infotrieve]
|
| 35.
|
Gao, J.,
Yin, D. H.,
Yao, Y.,
Sun, H.,
Qin, Z.,
Schöneich, C.,
Williams, T. D.,
and Squier, T. C.
(1998)
Biophys. J.
74,
1115-1134[Abstract/Free Full Text]
|
| 36.
|
Kruegar, J. K.,
Bishop, N. A.,
Blumenthal, D. K.,
Zhi, G.,
Beckingham, K.,
Stull, J. T.,
and Trewhella, J.
(1998)
Biochemistry
37,
17810-17817[CrossRef][Medline]
[Order article via Infotrieve]
|
| 37.
|
Persechini, A.,
and Kretsinger, R. H.
(1988)
J. Biol. Chem.
263,
12175-12178[Abstract/Free Full Text]
|
| 38.
|
Persechini, A.,
Jarrett, H. W.,
Kosk-Kosicka, D.,
Krinks, M. H.,
and Lee, H. G.
(1993)
Biochim. Biophys. Acta
1163,
309-314[CrossRef][Medline]
[Order article via Infotrieve]
|
| 39.
|
Persechini, A.,
Gansz, K. J.,
and Paresi, R. J.
(1996)
Biochemistry
35,
224-228[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Yao, Y.,
and Squier, T. C.
(1996)
Biochemistry
35,
6815-6827[CrossRef][Medline]
[Order article via Infotrieve]
|
| 41.
|
Peersen, O. B.,
Madsen, T. S.,
and Falke, J. J.
(1997)
Protein Sci.
6,
794-807[Abstract]
|
| 42.
|
Klee, C. B.
(1988)
in
Calmodulin
(Cohen, P.
, and Klee, C. B., eds)
, pp. 35-46, Elsevier Science Publishers B.V., Amsterdam
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea 